EquityBulls

Latest News

GRE Renew Enertech Reports 100 MWp Solar Portfolio; Consolidated EPC Order Book of 75 MWp, Worth Approximately ₹224 Crore
Mobavenue AI Tech Opens Singapore Hub to Scale AI-Native AdTech Across Southeast Asia
Powerica Secures 100MW Wind Project bid from SECI's Wind Power Tender
ACME Suryodaya Pvt Ltd commissions 110.336 MWh capacity of BESS project
Arisinfra Solutions Ltd secures order of Rs. 79.05 crores

Keywords Selected: Injection

Stock Report

Glenmark Pharmaceuticals Inc., USA launches Olanzapine for Injection, 10 mg/vial, Single-Dose Vial
Glenmark Pharmaceuticals Inc., USA launches Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial
Glenmark Pharmaceuticals Inc., USA launches Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), Single-Dose Vials
Lupin receives approval from U.S. FDA for Ranluspec™ (ranibizumab) Injection
NATCO and Lupin receive approval from U.S. FDA for Eribulin Mesylate Injection
Lupin Receives U.S. FDA Approval for Famotidine Injection, USP
Biocon Pharma Limited Receives Health Canada Approval for Micafungin for Injection, USP, 50 MG and 100 MG
Caplin Steriles Ltd gets USFDA approval for Calcium Gluconate Injection
OneSource Supports Second Generic Semaglutide Approval in Canada
OneSource's Partner Dr. Reddy's Laboratories receives Health Canada Approval for Generic Semaglutide Injection
Orbicular's Partner secures tentative U.S. ANDA approval for a generic version of Semaglutide Injection, supported by OneSource as CDMO partner
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Methotrexate Injection USP
Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection
Sun Pharma launches its semaglutide injection under the brand names, Noveltreat and Sematrinity in India
Zydus launches Semaglutide Injection in an innovative, reusable multi-dose pen device in India
NATCO Pharma Launches Semaglutide Generic Injection Multi Dose Vials in India at the Most Affordable Price Starting from MRP INR 1,290
Zydus and Torrent Pharma sign licensing agreement to co-market innovative Semaglutide Injection in India
Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India
Glenmark Pharmaceuticals Inc., USA to launch Potassium Phosphates Injections
Caplin Steriles gets USFDA approval for Potassium Phosphates Injection
Glenmark Pharmaceuticals Inc., USA to launch Sodium Phosphates Injection USP, 15 mM P/5 mL, 45 mM P/15 mL and 150 mM P/50 mL (3 mM P/mL) Single-Dose Vials
Zydus plans to launch innovative Semaglutide Injection in India on Day 1 of patent expiry
Caplin Steriles gets USFDA approval for Sodium Phosphates Injection
Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial